Systematic characterization of therapeutic vulnerabilities in Multiple Myeloma with Amp1q reveals increased sensitivity to the combination of MCL1 and PI3K inhibitors
Preprint in bioRxiv (August 2023)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Preprint in bioRxiv (August 2023)
Article in Asian Pacific Journal of Cancer Prevention (May 2022)
Article in Cancers (December 2021)